Harbor Capital Advisors, Inc. Rhythm Pharmaceuticals, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $1.29 Billion
- Q3 2025
A detailed history of Harbor Capital Advisors, Inc. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 37,205 shares of RYTM stock, worth $4.02 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
37,205
Previous 86,546
57.01%
Holding current value
$4.02 Million
Previous $5.47 Million
31.3%
% of portfolio
0.29%
Previous 0.23%
Shares
7 transactions
Others Institutions Holding RYTM
# of Institutions
248Shares Held
63.9MCall Options Held
210KPut Options Held
575K-
Black Rock Inc. New York, NY6.74MShares$728 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$605 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$601 Million7.68% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$527 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$388 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $6.02B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...